The Latest Breaking News on Pharma

AstraZeneca pauses £200m investment in Cambridge research site

Decision means none of drugmaker’s much-trumpeted £650m UK investment package is currently proceeding

The Guardian - UK · Sep 12, 2025

Jim Cramer Says Johnson & Johnson Stock Could Power Through $200 Next

Despite ongoing legal battles related to its talc products, Johnson Johnson (NYSE:JNJ) stock has climbed over 23% year-to-date.

Benzinga · Sep 12, 2025

Exclusive: Lutnick says Trump will force drugmakers to lower prices

Trump's efforts include reshaping drug prices through threats and public shaming.

Axios · Sep 12, 2025

Why Is AbbVie Stock Trading Higher On Thursday?

AbbVie Inc. (NYSE:ABBV) stock is trading higher on Thursday following an SEC filing that settled litigation with all generic manufacturers, which filed abbreviated new drug applications with the U.S. Food and Drug Administration for generic versions of upadacitinib tablets, marketed by the company as Rinvoq.

Benzinga · Sep 11, 2025

Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

The Independent UK · Sep 11, 2025

Big pharma will stop investing in UK, top scientist warns after Merck’s £1bn exit

Comments by former professor of medicine at Oxford follow scrapping of planned London research centre

The Guardian - UK · Sep 11, 2025

Merck scraps £1bn London expansion as report warns UK drugs sector ‘losing out’

UK pharmaceutical sector ‘risks losing investment to other countries’.

Evening Standard · Sep 11, 2025

BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) on Wednesday released topline exploratory efficacy data from the SERENITY At-Home Pivotal Phase 3 safety trial, which demonstrated that BXCL501 had continued effects and consistent benefit with repeat dosing.

Benzinga · Sep 10, 2025

Synopsys Shares Are Trading Lower Wednesday: What's Going On?

Synopsys, Inc. (NASDAQ:SNPS) shares are trading lower Wednesday after the company reported worse-than-expected financial results and issued fourth quarter adjusted earnings per share guidance below estimates on Tuesday after the market closed. Also, the company cut its fiscal-year 2025 adjusted earnings per share guidance below estimates.

Benzinga · Sep 10, 2025

US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs

New blow to UK’s key life science sector as industry body says country is losing ground on investment and research

The Guardian - UK · Sep 10, 2025